The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Revolution Medicines Inc shares valued at $140,811 were sold by Cislini Jeff on Nov 15 ’24. At $55.13 per share, Cislini Jeff sold 2,554 shares. The insider’s holdings dropped to 43,080 shares worth approximately $2.08 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, JEFFREY TODD CISLINI purchased 2,554 shares, netting a total of over 146,523 in proceeds.
Before that, Kelsey Stephen Michael had sold 16,666 shares from its account. In a trade valued at $977,509, the insider traded Revolution Medicines Inc shares for $58.65 each. Upon closing the transaction, the insider’s holdings decreased to 16,666 shares, worth approximately $12.76 million.
As published in a research note from Needham on July 16, 2024, Revolution Medicines Inc [RVMD] has been retained to a Buy and the price target has been revised to $62. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid July. As of July 08, 2024, Jefferies has initiated its “Buy” rating for RVMD. Earlier on April 12, 2024, Needham resumed its rating. Their recommendation was “a Buy” for RVMD stock.
Analyzing RVMD Stock Performance
During the last five days, there has been a drop of approximately -17.70%. Over the course of the year, Revolution Medicines Inc shares have jumped approximately 68.24%. Shares of the company reached a 52-week high of $62.40 on 11/11/24 and a 52-week low of $25.93 on 01/18/24. A 50-day SMA is recorded $51.94, while a 200-day SMA reached $41.98. Nevertheless, trading volume fell to 7.16 million shares from 4.19 million shares the previous day.
Support And Resistance Levels for Revolution Medicines Inc (RVMD)
According to the 24-hour chart, there is a support level at 46.29, which, if violated, would cause prices to drop to 44.32. In the upper region, resistance lies at 50.05. The next price resistance is at 51.84. RSI (Relative Strength Index) is 33.39 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -5.91, which suggests the price will decrease in the coming days. Percent R is at 84.34%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
